Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2011-10-20 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2011年第三季度报告正文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2011 Third Quarter Quarterly Report" of 嘉事堂药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as total assets, equity, revenue, net profit, cash flow, and other financial indicators for the third quarter ending September 30, 2011, as well as comparisons to previous periods. The document also includes management's discussion on significant changes in financial items, shareholder information, and other operational details. The length of the document (7,934 characters) and the presence of substantive financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q3 2011
2011-10-20 Chinese
2011年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2011 Third Quarter Quarterly Report" of 嘉事堂药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data such as balance sheets, profit and loss statements, cash flow information, and management discussion on financial performance and business conditions for the third quarter of 2011. The length is substantial (15,000 characters), and it includes actual financial statements and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2011
2011-10-20 Chinese
资产处置管理办法（2011年10月）
Governance Information Classification · 95% confidence The document is a detailed internal management policy titled '嘉事堂药业股份有限公司资产处置管理办法' (Asset Disposal Management Measures of Jia Shi Tang Pharmaceutical Co., Ltd.). It outlines procedures, responsibilities, and standards for asset disposal within the company, including definitions, approval processes, and accountability measures. There is no indication that this is a financial report, earnings release, regulatory filing, or announcement. It is a governance-related document detailing internal rules and procedures for asset management and disposal, which aligns with governance information. The document is not a report publication announcement or a certification. Therefore, the most appropriate classification is Governance Information (CGR).
2011-10-14 Chinese
关于完成工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the completion of industrial and commercial registration changes following a capital increase by converting capital reserves to share capital. It mentions the change in registered capital and the issuance of a new business license. The document is short (571 characters) and serves as a formal notice of the completion of a capital change process rather than a detailed financial report or a full capital change filing. Therefore, it fits best under the category of Share Issue/Capital Change announcements.
2011-10-14 Chinese
第三届董事会第十二次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the company's board of directors meeting, detailing decisions made such as investment approval, resignation of a securities affairs representative, asset disposal, and asset management procedures. It is not a full financial report, audit, or earnings release. It is not a regulatory filing or announcement of voting results but rather a record of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes in board or senior management and other board resolutions.
2011-10-14 Chinese
华泰联合证券有限责任公司关于公司《中小企业板上市公司内部控制规则落实情况自查表》的核查意见
Audit Report / Information Classification · 95% confidence The document is a verification opinion issued by the sponsoring securities company (华泰联合证券有限责任公司) regarding the internal control rules implementation self-inspection form of 嘉事堂药业股份有限公司, a company listed on the SME board. It discusses the company's self-inspection process, identified issues, and corrective plans related to internal control rules compliance. The document is not a full annual or interim report, nor is it a financial statement or earnings release. It is a specialized audit or verification opinion on internal control compliance, which fits the definition of an Audit Report / Information (AR). The document length is 2436 characters, which is short but contains substantive content of a verification opinion rather than just an announcement or certification letter. Therefore, it is classified as AR with high confidence. FY 2010
2011-09-22 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.